Dhingra Kapil
SEC insider (Form 3/4/5 filer). CIK 0001456849. Director at Black Diamond Therapeutics, Inc. (BDTX) and 3 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 26, 2026. Located in CAMBRIDGE, MA.
Companies Dhingra Kapil has filed insider reports for
- Black Diamond Therapeutics, Inc. (BDTX): Director
- Replimune Group, Inc. (REPL): Director
- LAVA Therapeutics NV (LVTX): Director
- CARGO Therapeutics, Inc. (CRGX): Director
Dhingra Kapil
CIK: 0001456849
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 26, 2026BDTX
Black Diamond Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Apr 1, 2026REPL
Replimune Group, Inc.
AwardDirectStock Option (right to buy)
44.5K shares- - Dec 9, 2025REPL
Replimune Group, Inc.
ExerciseDirect3.2K shares at avg. $1.75$6K - Dec 9, 2025REPL
Replimune Group, Inc.
SaleDirect3.2K shares at avg. $10.40$33K - Nov 13, 2025LVTX
LAVA Therapeutics NV
DispositionDirect30K shares- - Aug 19, 2025CRGX
CARGO Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares- - Jun 18, 2025CRGX
CARGO Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - Jun 12, 2025BDTX
Black Diamond Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
30.6K shares- - Apr 1, 2025REPL
Replimune Group, Inc.
AwardDirectStock Option (right to buy)
32K shares- - Feb 13, 2025LVTX
LAVA Therapeutics NV
AwardDirectCommon Shares (Right to Buy)
33.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 |  BDTX Black Diamond Therapeutics, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Apr 1, 2026 |  REPL Replimune Group, Inc. | Award Stock Option (right to buy) | 44,500 | - | - | Direct |
| Dec 9, 2025 | REPL Replimune Group, Inc. | Exercise | 3,169 | $1.75 | $5,546 | Direct |
| Dec 9, 2025 | REPL Replimune Group, Inc. | Sale | 3,169 | $10.40 | $32,958 | Direct |
| Nov 13, 2025 |  LVTX LAVA Therapeutics NV | Disposition | 30,000 | - | - | Direct |
| Aug 19, 2025 |  CRGX CARGO Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jun 18, 2025 | CRGX CARGO Therapeutics, Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jun 12, 2025 | BDTX Black Diamond Therapeutics, Inc. | Award Stock Option (Right to Buy) | 30,550 | - | - | Direct |
| Apr 1, 2025 | REPL Replimune Group, Inc. | Award Stock Option (right to buy) | 32,000 | - | - | Direct |
| Feb 13, 2025 | LVTX LAVA Therapeutics NV | Award Common Shares (Right to Buy) | 33,390 | - | - | Direct |
1-10 of 10 transactions